Nephrocare Health Services Ltd
Fri 22/05/2026,15:58:33 | NSE : NEPHROPLUS
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 589.90
Previous Close
₹ 585.45
Volume
507264
Mkt Cap ( Rs. Cr)
₹6095.70
High
₹ 618.75
Low
₹ 589.90
52 Week High
₹ 663.90
52 Week Low
₹ 446.00
Book Value Per Share
₹ 72.17
Dividend Yield
0.00
Face Value
₹ 2.00
What’s Your Call?
Collective community sentiment on Nephrocare Health Services Ltd
Your Vote -
Buy
66.67%
Hold
0.00%
Sell
33.33%
66.67%
3 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
22%
Sell Order Quantity
78%
Bid Price
Qty
613.00
225
612.00
65
612.00
75
612.00
7
611.00
1
Bid Total
2948
Bid Price
Qty
617.00
2
620.00
200
620.00
1111
622.00
20
624.00
10
Bid Total
10509
Option Chain
Analyzes market sentiment, predicts Nephrocare Health Services Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Nephrocare Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Nephrocare Health - Analysts/Institutional Investor Meet/Con. Call Updates
-
Nephrocare Health Q4 net profit jumps 92.06% at Rs 10.89 cr
-
Nephrocare Health - Analysts/Institutional Investor Meet/Con. Call Updates
-
Nephrocare Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
-
Nephrocare Health - Appointment
-
Nephrocare Health - Re-Appointment Of Internal Auditor
-
Nephrocare Health - Issuance Of Corporate Guarantee
-
Nephrocare Health - Giving guarantees/indemnity/ becoming a surety for third party
-
Nephrocare Health - Investor Presentation
-
Nephrocare Health - Announcement under Regulation 30 (LODR)-Investor Presentation
-
Nephrocare Health - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Nephrocare Health - Press Release
-
Nephrocare Health - Outcome of Board Meeting
-
Nephrocare Health - Board Meeting Outcome for Outcome Of The Board Meeting Held On May 19, 2026
-
Nephrocare Health - Monitoring Agency Report
-
Nephrocare Health - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
-
Nephrocare Health - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
-
Nephrocare Health - Agreements
-
Nephrocare Health - Analysts/Institutional Investor Meet/Con. Call Updates
-
Nephrocare Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Nephrocare Health - Board Meeting Intimation for Intimation Of Board Meeting For Considering Audited Financial Results Of The
-
Nephrocare Health has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026
-
Nephrocare Health - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Nephrocare Health - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Nephrocare Health - Appointment
-
Nephrocare Health - Announcement under Regulation 30 (LODR)-Change in Management
-
Nephrocare Health - Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
-
Nephrocare Health - Announcement Under Regulation 30 (LODR)- Disclosure Of Litigation Filed By The Company
-
Nephrocare Health - Trading Window
-
Nephrocare Health - Analysts/Institutional Investor Meet/Con. Call Updates
-
Nephrocare Health - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Key fundamentals
Evaluate the intrinsic value of Nephrocare Health Services Ltd stock
| Name | March-26 | March-25 | March-24 | ||
|---|---|---|---|---|---|
| Assets | 982.623 | 665.035 | 582.638 | ||
| Liabilities | 982.623 | 665.035 | 582.638 | ||
| Equity | 20.068 | 1.765 | 1.749 | ||
| Gross Profit | 88.167 | 94.883 | 51.964 | ||
| Net Profit | -8.06 | 34.236 | 3.882 | ||
| Cash From Operating Activities | 132.902 | 79.727 | 56.75 | ||
| NPM(%) | -1.27 | 6.29 | 0.88 | ||
| Revenue | 629.743 | 543.597 | 436.23 | ||
| Expenses | 541.576 | 448.714 | 384.266 | ||
| ROE(%) | -1.11 | 4.72 | 0.53 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Nephrocare Health Services Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 705.80 | -0.07 | 0.00 | 346.71 | -26.19 | 0.71 |
| Lotus Eye Hospital and Institute Ltd | 109.19 | 1.26 | 352.23 | 1263.38 | 3.55 | 0.00 |
| Vaishali Pharma Ltd | 7.00 | 0.14 | 0.00 | 7925.57 | 3.13 | 0.00 |
| Astec Lifesciences Ltd | 771.80 | 4.77 | 0.00 | 1191.39 | -363.15 | 0.00 |
Company Info
Our Company was incorporated as "Nephrocare Health Services Private Limited", a private limited company under the Companies Act, 1956, at Hyderabad with a certificate of incorporation issued by the Assistant Registrar of Companies, Andhra Pradesh ("RoC Andhra Pradesh") on December 18, 2009. Pursuant to resolutions dated April 11, 2025 and June 2, 2025 passed by our Board and Shareholders, respectively, our Company was converted into a public limited company and consequently, the name of our Company was changed to "Nephrocare Health Services Limited" with a fresh certificate of incorporation dated June 18, 2025 issued by the Registrar of Companies, Central Registration Centre.Major events and milestones:2010- Launched our first standalone clinic in Banjara Hills, Hyderabad, India.2012- Launched our first Public Private Partnership ("PPP") clinic in Sananth Nagar, Hyderabad, India2015- Launched 50th dialysis clinic and crossed 10,000 treatments per month2018- Acquired DaVita Care (India) Private Limited, the Indian arm of DaVita Care Pte Ltd.2020- Launched operations in Philippines by acquiring Royal Care Dialysis Center, Inc2022- Launched operations in Uzbekistan after the award of PPP tender.2024- Acquired a network of six clinics in Philippines pursuant to the acquisition of Renal Therapy Solutions Inc.2025- Acquired and a chain of seven clinics (AIZ Hemodialysis Center Inc., Bioregen Hemo Center Inc., Carmona Dialysis System Inc., Infini Care Health Systems Inc., and Kolff Dialysis Inc.)- Crossed 500 clinic globally
Our Company was incorporated as "Nephrocare Health Services Private Limited", a private limited company under the Companies Act, 1956, at Hyderabad with a certificate of incorporation issued by the Assistant Registrar of Companies, Andhra Pradesh ("RoC Andhra Pradesh") on December 18, 2009. Pursuant to resolutions dated April 11, 2025 and June 2, 2025 passed by our Board and Shareholders, respectively, our Company was converted into a public limited company and consequently, the name of our Company was changed to "Nephrocare Health Services Limited" with a fresh certificate of incorporation dated June 18, 2025 issued by the Registrar of Companies, Central Registration Centre.Major events and milestones:2010- Launched our first standalone clinic in Banjara Hills, Hyderabad, India.2012- Launched our first Public Private Partnership ("PPP") clinic in Sananth Nagar, Hyderabad, India2015- Launched 50th dialysis clinic and crossed 10,000 treatments per month2018- Acquired DaVita Care (India) Private Limited, the Indian arm of DaVita Care Pte Ltd.2020- Launched operations in Philippines by acquiring Royal Care Dialysis Center, Inc2022- Launched operations in Uzbekistan after the award of PPP tender.2024- Acquired a network of six clinics in Philippines pursuant to the acquisition of Renal Therapy Solutions Inc.2025- Acquired and a chain of seven clinics (AIZ Hemodialysis Center Inc., Bioregen Hemo Center Inc., Carmona Dialysis System Inc., Infini Care Health Systems Inc., and Kolff Dialysis Inc.)- Crossed 500 clinic globally
Read More
Parent Organisation
Nephrocare Health Services Ltd.
Founded
18/12/2009
Managing Director
Mr.Vikram Vuppala
NSE Symbol
NEPHROPLUSEQ
FAQ
The current price of Nephrocare Health Services Ltd is ₹ 607.50.
The 52-week high for Nephrocare Health Services Ltd is ₹ 618.75 and the 52-week low is ₹ 589.90.
The market capitalization of Nephrocare Health Services Ltd is currently ₹ 6095.70. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Nephrocare Health Services Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Nephrocare Health Services Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Nephrocare Health Services Ltd shares.
The CEO of Nephrocare Health Services Ltd is Mr.Vikram Vuppala, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
